Lundbeck Limited

Lundbeck House, Caldecotte Lake Business Park, Caldecotte, Milton Keynes, MK7 8LG
Telephone: +44 (0)1908 649 966
Fax: +44 (0)1908 647 888
WWW: http://www.lundbeck.co.uk
Medical Information Direct Line: +44 (0)1908 638 972
Medical Information e-mail: ukmedicalinformation@lundbeck.com
Customer Care direct line: +44 (0)1908 638 935
Patient Information Leaflet last updated on the eMC: 22/01/2009
PIL Ebixa 10 mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/01/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 23/09/2008 and displayed until 22/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 25/06/2008 and displayed until 23/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 02/01/2008 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 01/06/2006 and displayed until 02/01/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 02/02/2006 and displayed until 01/06/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 09/09/2002 and displayed until 02/02/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   memantine


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk